Hydrogen sulfide modulates epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via HIF-1α activation

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Julian R. Molina, Ping Yang, Stephen D. Cassivi et al. · Mayo Clinic Proceedings · 2008 · 2.9K citations

Medicine, Oncology, Radiation Oncology +14

Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer

Csaba Szabó, Ciro Coletta, Celia Chao et al. · Proceedings of the National Academy of Sciences · 2013 · 753 citations · Full text

Medicine, Oncology, Pharmacology +15

Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists.

Ewelina Łowicka, Jerzy Bełtowski · PubMed · 2007 · 567 citations

Medicine, Chemistry, Pharmacology +3

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials

Wenfeng Fang, Yunpeng Yang, Yuxiang Ma et al. · The Lancet Oncology · 2018 · 507 citations

Medicine, Oncology, Pharmacology +13

Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells

Hiroaki Kajiyama, Kiyosumi Shibata, Mikio Terauchi et al. · International Journal of Oncology · 2007 · 409 citations · Full text

Medicine, Oncology, Pharmacology +17